New Guidelines acknowledge difficulties around examining computer-implemented inventions, and are also important for new technologies with developing terminologies, where it may be hard to describe an invention in words
Therapies based on human embryonic stem cells should not be granted patents, according to the latest opinion from the Court of Justice of the European Union. If confirmed, this will have a major impact on stem cell research in Europe and on the European life sciences industry as a whole
The recent ruling by the Court of Justice of the European Union that DNA patents are not infringed if the DNA in question is not functional, may make it harder for companies to enforce such patents
New measures are needed for Europe meets its 2020 target of a 20 per cent improvement in energy efficiency. Building intelligence into the electricity grid is one concrete way to achieve this
The European Commission and the European Molecular Biology Laboratory have formalised their intention to maintain and further develop their cooperation.
As the second tranche of projects in the €2 billion Innovative Medicines Initiative was announced this week, a quick stock take of progress to date hints at what this wide-ranging collaboration could deliver
The European Court of Justice has thrown a huge spanner into the plans for a single Court to deal with patent disputes, saying it is incompatible with EU law
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.